Reckitt Benckiser Group (OTCMKTS:RBGLY) Upgraded at Morgan Stanley

Morgan Stanley upgraded shares of Reckitt Benckiser Group (OTCMKTS:RBGLY) from an equal weight rating to an overweight rating in a research report sent to investors on Monday, Marketbeat Ratings reports.

A number of other equities analysts have also weighed in on RBGLY. Barclays upgraded Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a research note on Monday, December 1st. Royal Bank Of Canada downgraded Reckitt Benckiser Group from an “outperform” rating to a “sector perform” rating in a research note on Wednesday, January 14th. Jefferies Financial Group reiterated a “hold” rating on shares of Reckitt Benckiser Group in a research report on Wednesday, January 7th. Zacks Research raised Reckitt Benckiser Group to a “hold” rating in a report on Tuesday, March 3rd. Finally, Citigroup initiated coverage on shares of Reckitt Benckiser Group in a research report on Wednesday, January 14th. They issued a “buy” rating for the company. Two analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy”.

Reckitt Benckiser Group Price Performance

Reckitt Benckiser Group stock opened at $14.07 on Monday. The company’s 50-day moving average price is $16.48 and its two-hundred day moving average price is $15.93. The company has a debt-to-equity ratio of 1.01, a current ratio of 0.56 and a quick ratio of 0.37. Reckitt Benckiser Group has a twelve month low of $12.49 and a twelve month high of $17.80.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc is a multinational consumer goods company that develops, manufactures and markets health, hygiene and home products. Its portfolio spans over-the-counter medicines and health products, personal and sexual wellness, surface and laundry cleaning, and household care. The company owns a number of well-known global brands across these categories, including Lysol and Dettol in disinfectants and hygiene, Durex in sexual wellness, Nurofen in analgesics, and Finish in dishwashing products.

The firm has its corporate headquarters in the United Kingdom and sells products in markets around the world, serving consumers across North America, Europe, Asia, Latin America, the Middle East and Africa.